Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Current Liabilities (2016 - 2025)

Veracyte (VCYT) has disclosed Total Current Liabilities for 14 consecutive years, with $59.9 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 23.78% to $59.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.9 million through Dec 2025, down 23.78% year-over-year, with the annual reading at $59.9 million for FY2025, 23.78% down from the prior year.
  • Total Current Liabilities hit $59.9 million in Q4 2025 for Veracyte, down from $72.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $78.6 million in Q4 2024 to a low of $32.7 million in Q1 2021.
  • Historically, Total Current Liabilities has averaged $61.1 million across 5 years, with a median of $60.6 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: soared 282.28% in 2021 and later decreased 23.78% in 2025.
  • Year by year, Total Current Liabilities stood at $64.2 million in 2021, then dropped by 2.4% to $62.6 million in 2022, then fell by 2.19% to $61.2 million in 2023, then rose by 28.4% to $78.6 million in 2024, then fell by 23.78% to $59.9 million in 2025.
  • Business Quant data shows Total Current Liabilities for VCYT at $59.9 million in Q4 2025, $72.2 million in Q3 2025, and $76.4 million in Q2 2025.